153 related articles for article (PubMed ID: 32696043)
21. Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.
Ikawa T; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
Arthritis Res Ther; 2021 Nov; 23(1):283. PubMed ID: 34774095
[TBL] [Abstract][Full Text] [Related]
22. Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis.
Omatsu J; Saigusa R; Miyagawa T; Fukui Y; Toyama S; Awaji K; Ikawa T; Norimatsu Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2021 Mar; 30(3):409-415. PubMed ID: 33068321
[TBL] [Abstract][Full Text] [Related]
23. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.
Asano Y; Bujor AM; Trojanowska M
J Dermatol Sci; 2010 Sep; 59(3):153-62. PubMed ID: 20663647
[TBL] [Abstract][Full Text] [Related]
24. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
[TBL] [Abstract][Full Text] [Related]
25. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
[TBL] [Abstract][Full Text] [Related]
26. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
27. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.
Miura S; Watanabe Y; Saigusa R; Yamashita T; Nakamura K; Hirabayashi M; Miyagawa T; Yoshizaki A; Trojanowska M; Sato S; Asano Y
Arthritis Res Ther; 2021 May; 23(1):137. PubMed ID: 33964960
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in animal models of systemic sclerosis.
Asano Y
J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
[TBL] [Abstract][Full Text] [Related]
31. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.
Takahashi T; Asano Y; Sugawara K; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Toyama T; Taniguchi T; Akamata K; Noda S; Yoshizaki A; Tsuruta D; Trojanowska M; Sato S
J Exp Med; 2017 Apr; 214(4):1129-1151. PubMed ID: 28232470
[TBL] [Abstract][Full Text] [Related]
32. Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients.
Takeuchi F; Nabeta H; Füssel M; Conrad K; Frank KH
Ann Rheum Dis; 2000 Apr; 59(4):293-6. PubMed ID: 10733477
[TBL] [Abstract][Full Text] [Related]
33. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
Zhou X; Tan FK; Stivers DN; Arnett FC
Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
[TBL] [Abstract][Full Text] [Related]
34. Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.
Saigusa R; Asano Y; Nakamura K; Hirabayashi M; Miura S; Yamashita T; Taniguchi T; Ichimura Y; Takahashi T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Invest Dermatol; 2017 Sep; 137(9):1850-1859. PubMed ID: 28528914
[TBL] [Abstract][Full Text] [Related]
35. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
[TBL] [Abstract][Full Text] [Related]
36. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
[TBL] [Abstract][Full Text] [Related]
37. Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.
Chairta P; Psarelis S; Michailidou K; Demetriou C; Symeonidou S; Nicolaou P; Christodoulou K
Genet Test Mol Biomarkers; 2020 May; 24(5):309-317. PubMed ID: 32315557
[No Abstract] [Full Text] [Related]
38. FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.
Castellucci L; Jamieson SE; Miller EN; de Almeida LF; Oliveira J; Magalhães A; Guimarães LH; Lessa M; Lago E; de Jesus AR; Carvalho EM; Blackwell JM
Genes Immun; 2011 Oct; 12(7):589-94. PubMed ID: 21633373
[TBL] [Abstract][Full Text] [Related]
39. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Baños-Hernández CJ; Navarro-Zarza JE; Bucala R; Hernández-Bello J; Parra-Rojas I; Ramírez-Dueñas MG; García-Arellano S; Hernández-Palma LA; Machado-Sulbarán AC; Muñoz-Valle JF
Clin Rheumatol; 2019 Jun; 38(6):1643-1654. PubMed ID: 30747392
[TBL] [Abstract][Full Text] [Related]
40. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
